Načítá se...
Temozolomide resistance in glioblastoma multiforme
Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas. However, at least 50% of TMZ treated patients do not respond to TMZ. This is due primarily to the over-expression of O(6)-methylguanine methyltransferase (MGMT) and/or lack of a DNA repair pa...
Uloženo v:
| Vydáno v: | Genes Dis |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Chongqing Medical University
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6150109/ https://ncbi.nlm.nih.gov/pubmed/30258889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2016.04.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|